Target intelligence / Profile preview

Host antigen-presenting cells and immune system components (Host APCs)

Target
Host APCs
Molecular classification
Other (Cellular population), Immune system
01

Overview

Host antigen-presenting cells (APCs), including dendritic cells, macrophages, and B cells, are specialized immune cells responsible for capturing, processing, and presenting antigens to T lymphocytes via major histocompatibility complex (MHC) molecules (StatPearls: NBK546619). This process, supported by costimulatory signals such as CD80 and CD86, is fundamental to the initiation of adaptive immune responses. In clinical contexts such as allogeneic hematopoietic stem cell transplantation, host APCs are critical mediators of Graft-versus-Host Disease (GvHD), as they present host-derived alloantigens to donor T cells (Nature Reviews Immunology, 2007). While various immunosuppressive drugs target the molecular interactions between APCs and T cells, the term itself refers to a heterogeneous cellular population and systemic network rather than a single molecular entity. Consequently, it is categorized as a broad biological system rather than a discrete therapeutic target like a specific receptor or enzyme.

Other names
Professional antigen-presenting cellsHost APCsImmune system components
02

Mechanism of action

Pharmacological modulation of this system typically involves the inhibition of T-cell costimulation (e.g., blocking the CD80/86-CD28 interaction) or the suppression of intracellular signaling pathways required for T-cell activation following antigen presentation (StatPearls: NBK546619).

03

Biological functions

Antigen processingAntigen presentationT-cell activationImmune surveillanceCytokine production
04

Disease associations

Graft-versus-host diseaseAutoimmune diseaseCancerInfectionTransplant rejection
05

Safety considerations

Systemic immunosuppressionIncreased risk of opportunistic infectionsReduced vaccine efficacyPotential for secondary malignancies with chronic use
06

Interacting drugs

Abatacept

5 more in the full profile.

07

Biomarkers

HLA-DR expressionCD80CD86CD40Circulating dendritic cell counts

Beyond the preview

Go deeper on Host antigen-presenting cells and immune system components (Host APCs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host antigen-presenting cells and immune system components (Host APCs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call